MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-15-0005567
Jagota Pharma & Sons Private Limited
Jagota Pharma & Sons Private Limited - pharma in Bareilly, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹9.63 Cr
▼ 2% YoY
Net profit · FY 2024
₹2.73 Lakh
Net margin 0.3%
EBITDA · FY 2024
₹13.3 Lakh
EBITDA margin 1.4%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹1.25 Cr
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
About Jagota Pharma & Sons Private Limited
Data last updated:
Jagota Pharma & Sons Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74900UP2014PTC064316. Its GSTIN is 09AADCJ3379H1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Rakesh Bhandari and Aanchal Jauhri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ist Floor Kashish Complex Shastri Market, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.63 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.73 Lakh (net margin 0.3%) and EBITDA of ₹13.3 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹1.25 Cr on record.
Jagota Pharma & Sons Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-15-0005567). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900UP2014PTC064316
Registration Number 064316
Incorporation Date 12 June 2014
ROC Kanpur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-15-0005567
Recognitions & Rankings of Jagota Pharma & Sons
Contact details
Jagota Pharma & Sons Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressIst Floor Kashish Complex Shastri Market, Bareilly, Uttar Pradesh, India – 243001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jagota Pharma & Sons Private Limited, buy the company report.
Comprehensive company report
Jagota Pharma & Sons Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jagota Pharma & Sons is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jagota Pharma & Sons Private Limited, buy the company report.
Financials of Jagota Pharma & Sons Private Limited
FY 2025 filings availableJagota Pharma & Sons Private Limited reported revenue of ₹9.63 Cr (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹9.63 Cr ▼ 2%
Net profit · FY 2024
₹2.73 Lakh margin 0.3%
EBITDA · FY 2024
₹13.3 Lakh margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 8%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 2%
5 years · compounded
▲ 1%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jagota Pharma & Sons Private Limited, buy the company report.
Board of directors of Jagota Pharma & Sons Private Limited
Jagota Pharma & Sons has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Bhandari | Director | 12 Jun 2014 | 12 Years 5 Months | Current |
| Aanchal Jauhri | Director | 30 Nov 2024 | 1 Years 11 Months | Current |
| Minisha Bass | Director | 12 Jun 2014 | 12 Years 5 Months | Current |
Auditor
Jagota Pharma & Sons Private Limited is audited by ANUJ RASTOGI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUJ RASTOGI & ASSOCIATES | FY 2023 | 0025664C |
Shareholding
The shareholding of Jagota Pharma & Sons Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jagota Pharma & Sons Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
₹1.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Aug 2017 | 100131632 | Others | ₹2 Cr | Open | |
| 07 May 2015 | 10572235 | Punjab and Sind Bank | ₹1.25 Cr | Satisfied |
To see the full charge records of Jagota Pharma & Sons Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Jagota Pharma & Sons Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jagota Pharma & Sons Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jagota Pharma & Sons has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCJ3379H1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jagota Pharma & Sons Private Limited, buy the company report.
Recent activity
Jagota Pharma & Sons Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Aanchal Jauhri ceased to be Additional Director on 29 Sep 2025.
AGM
Jagota Pharma & Sons Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Aanchal Jauhri ceased to be Additional Director.
Filing
Jagota Pharma & Sons Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Aanchal Jauhri was appointed as Director.
Charges
A charge with Others of Rs. 200.00 Lakh registered on 28 Aug 2017 with Charge ID 100131632 was modified on 20 May 2024.
Ceased
Jitendra Pal Singh ceased to be Director.
Charges
A charge registered on 07 May 2015 via Charge ID 10572235 with Punjab And Sind Bank was fully satisfied on 04 Oct 2017.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100131632 was registered on 28 Aug 2017.
Charges
A charge with Punjab And Sind Bank amounted to Rs. 125.00 Lakh with Charge ID 10572235 was registered on 07 May 2015.
Ceased
Naveen Kumar ceased to be Director.
Appointed
Minisha Bass was appointed as Director.
Appointed
Rakesh Bhandari was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Jagota Pharma & Sons is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 June 2014 (12+ years old) and is registered under CIN U74900UP2014PTC064316.
Jagota Pharma & Sons has 3 current directors:
- Rakesh Bhandari - Director
- Aanchal Jauhri - Director
- Minisha Bass - Director
The latest financial statements of Jagota Pharma & Sons on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jagota Pharma & Sons is 09AADCJ3379H1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Jagota Pharma & Sons is U74900UP2014PTC064316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jagota Pharma & Sons was incorporated on 12 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
Aanchal Jauhri ceased to be Additional Director on 29 Sep 2025. Aanchal Jauhri was appointed as Director on 30 Nov 2024. Jitendra Pal Singh ceased to be Director on 02 Jan 2019. Jagota Pharma & Sons has 6 board changes on record in total.
Yes, Jagota Pharma & Sons is registered as a small enterprise under Udyam registration (number: UDYAM-UP-15-0005567).
The registered office of Jagota Pharma & Sons is at Ist Floor Kashish Complex Shastri Market, Bareilly, Uttar Pradesh, India – 243001.
Jagota Pharma & Sons operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages